Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
about
Oral deferiprone for iron chelation in people with thalassaemiaOral deferiprone for iron chelation in people with thalassaemiaImproved R2* measurements in myocardial iron overload.MRI detects myocardial iron in the human heart.Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
P2860
Q24200309-B0335B4D-CB88-489F-9C9D-A4E807E1D9A2Q24244045-2A976D4B-693A-4270-B3AB-DB30A25B2B09Q31023513-6FE998A3-85F1-4C38-A48E-15A6B1113616Q33921092-3E0E5168-B6C6-42F2-A058-B29091BBF45EQ33958448-E20B450F-CCCF-459A-832F-D489EB9C0F9EQ36915101-A5D9D7E7-F853-418E-A27E-0F7BA7F72785Q48553203-483BBB4D-7E4E-4D48-A854-B2D9E4825842
P2860
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@nl
type
label
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@nl
prefLabel
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@nl
P1433
P1476
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
@en
P2093
T G St Pierre
P304
182; author reply 183-4
P356
10.1016/S0140-6736(03)12221-0
P407
P577
2003-01-01T00:00:00Z